FDA Inspection
Henry A Frazer, Pharm D, Clinical InvestigatorHenry A Frazer, Pharm D, Clinical Investigator – FDA Inspection, Oct 3, 2012
Record Details
This FDA Inspection record concerns Henry A Frazer, Pharm D, Clinical Investigator, with an inspection on October 3, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 3, 2012
- Product Type
- Drugs
View Company Profile
ID · 2a752939-7168-4229-aea1-36efc7826cb9
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 803391
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Henry A Frazer, Pharm D, Clinical Investigator
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 3, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 14, 2009 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Henry A Frazer, Pharm D, Clinical Investigator
- FDA Inspection 876725 - 2014-04-03
- FDA Inspection 581025 - 2009-05-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.